Alpha Omega Wealth Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Alpha Omega Wealth Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-112	Closed	-$6K	–	514
2017 Q4	$6K	Sell	112 -50	-31%	-$2.74K	﹤0.01%	389
2017 Q3	$9K	Hold	162	–	–	﹤0.01%	360
2017 Q2	$10K	Hold	162	–	–	0.01%	344
2017 Q1	$9K	Buy	+162	New	+$7.98K	﹤0.01%	358

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Alpha Omega Wealth Management's BIVV Position: Q1 2018 in Review

Alpha Omega Wealth Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 112 shares — an estimated $6K sold.

Alpha Omega Wealth Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $10K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Alpha Omega Wealth Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Alpha Omega Wealth Management sold 112 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $6K.
Alpha Omega Wealth Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Alpha Omega Wealth Management's Bioverativ Inc. Common Stock position peaked at $10K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Alpha Omega Wealth Management's 13F filing for Q1 2018, filed 1 May 2018.